Blumcke et al, “The apolipoprotein E e4 allele is not associated with early onset temporal lobe epilepsy”, Neuroreport 8: 1235-1237, 1997.* |
Lehtimaki et al, “The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia”, Acta Neurol. Scand. 93:352-354, 1996.* |
Stone et al., “Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNA in Vivo and in Vitro,” Exp. Neurol., 143(2):313-318 (1997). |
Bartels et al., “DNA Mutations Associated with the Human Butyrylcholinesterase J-Variant”, Am. J. Hum. Genet. 50:1104-1114 (1992). |
Bartels et al., “DNA Mutation Associated with the Human Butyrylcholinesterase K-Variant and Its Linkage to the Atypical Variant Mutation and Other Polymorphic Sites”, Am. J. Hum. Genet. 50:1086-1103 (1992). |
Bartus et al., “The Cholinergic Hypothesis of Geriatric Memory Dysfunction”, Science 217:408-417 (1982). |
Bertrand et al., “Association of apolipoprotein E genotype with brain levels of apolipoprotein E and Apolipoprotein J(clusterin) in Alzheimer disease”, Mol. Brain. Res. 33:174-178 (1995). |
Boyles et al., “Apolipoprotein E Associated with Astrocytic Glia of the Central Nervous System with Nonmyelinating Glia of the Peripheral Nervous System”, J. Clin. Invest. 76:1501-1513 (1985). |
Brindle et al., “Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease”, Hum. Mol. Genet. 7:933-935 (1998). |
Corder et al., “Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families”, Science 261:921-923 (1993). |
Goodrum, “Cholesterol Synthesis is Down-Regulated During Regeneration of Peripheral Nerve”, J. Neurochem. 54:1709-1715 (1990). |
Inestrosa et al., “Acetylcholinesterase Accelerates Assembly of Amyloid-62 -Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme”, Neuron 16:881-891 (1996). |
Koo et al., “Obligatory Role of Cholesterol and Apolipoprotein E in the Formation of Large Cholesterol-enriched and Receptor-active High Density Lipoproteins”, J. Biol. Chem. 260:11934-11943 (1985). |
La Du et al., “Phenotypic and Molecular Biological Analysis of Human Butyrylcholinesterase Variants”, Clin. Biochem. 23:423-431 (1990). |
LeBlanc et al., “Regulation of Apolipoprotein E Gene Expression After Injury of the Rat Sciatic Nerve”, J. Neurosci. Res25:162-171 (1990). |
Lehmann et al., “Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease”, Hum. Mol. Genet. 6:1933-1936 (1977). |
Maekawa et al., “Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan”, Clin. Chem. 43:924-929 (1997). |
Masliah et al., “Neurodegeneration in the Central Nervous System of apoE-Deficient Mice”, Exp. Neurol. 136:107-122, 1995. |
Masliah et al., “Apolipoprotein E Role in Maintaining the Integrity of the Aging Central Nervous System”, Springer-Verlag, Heidelberg pp. 59-73 (1996). |
Nalbantoglu et al., “Predictive Value of Apolipoprotein E Genotyping in Alzheimer's Disease: Results of an Autopsy Series and an Analysis of Several Combined Studies”, Ann. Neurol. 36:889-895 (1994). |
Noguchi et al., “Apolipoprotein E genotype and Alzheimer's disease”, The Lancet (letter) 342:737 (1993). |
Payami et al., “Apolipoprotein E genotype and Alzheimer's disease”, The Lancet (letter) 342:737-738 (1993). |
Poirier et al., “Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease”, Proc. Natl. Acad. Sci. 92:12260-12264 (1995). |
Poirier et al., “Cholesterol Synthesis and Lipoprotein Reputake During Synaptic Remodelling in Hippocampus in Adult Rats”, Neuroscience 55:81-90 (1993). |
Poirier et al., “Apolipoprotein E polymorphism and Alzheimer's disease”, The Lancet 342:697-699 (1993). |
Poirier et al., “Apolipoprotein E4, Cholinergic Integrity and Synaptic Plasticity and Alzheimer's Disease”, Springer-Verlag, Heidelberg pp. 20-28 (1996). |
Poirier et al., “Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning”, Mol. Brain. Res. 11:97-106 (1991). |
Poirier et al., “Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat”, Mol. Brain. Res. 9:191-195 (1991). |
Reed et al., “Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele”, Arch. Neurol. 51:1189-1192 (1994). |
Richard et al., “ApoE genotyping and response to drug treatment in Alzheimer's disease”, The Lancet 349:519 (1997). |
Rothe et al., “Uptake of Endoneurial Lipoprotein Into Schwann Cells and Sensory Neurons is Mediated by Low Density Lipoprotein Receptors and Stimulated After Axonal Injury”, J. Neurochem. 57:2016-2025 (1991). |
Russ et al., “K variant of butyrylcholinesterase and late-onset Alzheimer's disease”, The Lancet 351:881 (1998). |
Schellenberg et al., “Genetic Association and Linkage Analysis of the Apolipoprotein CII Locus and Familial Alzheimer's Disease”, Annals of Neurology 31:223-227 (1992). |
Singleton et al., “No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease”, Hum Mol Genet 7:937-939 (1998). |